VCYT VERACYTE, INC.

VCYT financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1384101 Exchange: Nasdaq SIC: 8071 (Services-Medical Laboratories)
Showing 3 of 15 annual and 0 of 55 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Large accelerated filer
Entity Type
Operating
Public Float
$1.70B (Jun 2025)
Industry (SIC)
8071 Services-Medical Laboratories
Incorporated
DE
Fiscal Year End
December (1231)
Phone
(650) 243-6300
EIN
205455398
Headquarters
SOUTH SAN FRANCISCO, CA, 94080
Public Float History
Market value of shares held by public investors, reported in annual DEI filings.
Former Names: CALDEROME INC (2006–2008)

▼ Key Metrics (TTM)

As of Jun 30, 2026
Financials
Revenue
$561.90M
Net Income
$114.48M
Total Assets
$1.49B
Total Equity
$1.39B
Total Debt
-
Free Cash Flow
$165.99M
Ratios
Gross Margin
71.7%
Operating Margin
18.8%
Net Margin
20.4%
Return on Equity
8.2%
Return on Assets
7.7%
Current Ratio
9.16x
FCF / Assets
11.2%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

Fiscal 2025 results for VERACYTE, INC. combined $517.14M of revenue with net income of $66.35M and an operating cash inflow of $136.31M. At $517.14M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Compared with $445.76M in fiscal 2024, revenue recorded a 16.0% year-over-year increase. The company reported diluted EPS of $0.82, adding a shareholder-level measure to the absolute income figures considered below. The per-share result recorded a 164.5% increase from fiscal 2024 diluted EPS of $0.31. Asset turnover was 0.37x, relating the company’s annual revenue directly to the total assets reported at the period end.

Profitability

After reported cost of revenue, the company retained $362.53M as gross profit before recognizing operating expenses and other items. Gross margin was 70.1%, so that share of each revenue unit remained after the cost of revenue reported for the period. Operations produced $57.78M of income after the reported operating expense base, before the remaining non-operating and tax effects. The operating result equaled 11.2% of revenue, placing the absolute operating-income figure in the context of the company’s sales base. The bottom-line result was net income of $66.35M, after the operating, financing, tax, and other items recognized for the period. Measured against reported revenue, net income produced a 12.8% margin after operating costs and the remaining recognized items. The earnings statement records $68.20M of pretax income, the profit base against which the reported tax provision can be assessed. Pretax income represented 13.2% of revenue, placing earnings before tax in the context of the company’s operating scale. The company recognized $1.85M of income tax for the period, completing the transition from pretax income to net income. Relative to pretax income, the tax provision measured 2.7%, quantifying the portion of pre-tax earnings paid in income tax. Return on period-end equity was 5.1%, relating annual net income to the equity capital on the balance sheet. The net-income-to-assets relationship measured 4.7%, showing earnings relative to the full balance sheet.

Liquidity and Capital Structure

Total assets were $1.41B, supported by $96.44M of liabilities and $1.31B of shareholder equity. The near-term balance sheet paired $488.38M of current assets with $59.94M of current liabilities at the reporting date. At 8.15x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Reported cash and equivalents were $362.58M, separating immediately recognizable cash resources from the rest of the current-asset base. Measured only with cash and equivalents, coverage of current liabilities was 604.9%, excluding receivables and other current assets. The liabilities-to-assets relationship was 6.9%, placing reported obligations against the full positive asset balance. Cash and equivalents equaled 25.8% of total assets, showing the liquid cash component within the company’s broader resource base. The asset base changed 8.2% from $1.30B in fiscal 2024, leaving current total assets higher year over year.

Cash Flow and Earnings Quality

Cash flow from operations was $136.31M, a reported cash inflow that can be compared directly with net income and capital spending. Against net income, operating cash flow measured 2.05x, showing the relationship between accrual earnings and operating cash. Capital spending was $9.68M, absorbing part of the cash generated from operations before free cash flow. Relative to operating cash flow, capital expenditures measured 7.1%, connecting investment intensity with the company’s cash-generation base. The combination of operating cash flow and capital spending produced $126.63M of positive free cash flow for the period. Free cash flow represented 24.5% of revenue, linking post-investment cash generation with the company’s operating scale. The free-cash-flow-to-assets relationship was 9.0%, comparing post-investment cash with the balance-sheet asset base.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for VERACYTE, INC.
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $517.15M $445.76M $361.05M
Gross Profit $362.53M $298.15M $229.68M
OPERATING EXPENSES
R&D Expense $70.81M $69.29M $57.31M
SG&A Expense $110.78M $110.61M $86.23M
Other Operating Expenses (derived) $123.16M $102.10M $171.95M
Operating Income $57.78M $16.14M $-85.80M
NON-OPERATING INCOME / EXPENSE
Other Income/Expense $10.42M $9.60M $9.18M
Pretax Income $68.20M $25.74M $-76.61M
Income Tax $1.85M $1.61M $-2.21M
Net Income $66.35M $24.14M $-74.40M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.82 $0.31 $-1.02
Diluted Shares 80.57M 78.16M 72.64M
EBITDA $79.19M $39.60M $-58.61M
Depreciation & Amortization $21.42M $23.46M $27.19M
Balance Sheet
ASSETS
Cash & Equivalents $362.58M $239.09M $216.45M
Accounts Receivable $44.66M $46.53M $40.38M
Inventory $20.55M $21.75M $16.13M
Other Current Assets $10.28M $14.55M $12.66M
Current Assets $488.38M $372.27M $285.62M
PP&E (Net) $22.19M $22.95M $20.58M
Goodwill $767.15M $745.80M $702.98M
Intangible Assets $89.15M $102.30M $88.59M
Other Noncurrent Assets $902.00K $6.98M $5.97M
Noncurrent Assets $917.64M $927.77M $829.29M
Total Assets $1.41B $1.30B $1.11B
LIABILITIES
Accounts Payable $4.59M $8.63M $12.94M
Other Current Liabilities $0 $19.00K $101.00K
Current Liabilities $59.94M $78.63M $61.24M
Other Noncurrent Liabilities $0 $411.00K $786.00K
Noncurrent Liabilities $36.51M $45.44M $9.56M
Total Liabilities $96.44M $124.07M $70.80M
EQUITY
Common Stock $79.00K $78.00K $73.00K
Additional Paid-in Capital $1.70B $1.66B $1.54B
Retained Earnings $-377.63M $-443.98M $-468.12M
Accumulated OCI $-8.21M $-36.09M $-24.02M
Total Equity $1.31B $1.18B $1.04B
Total Liabilities & Equity $1.41B $1.30B $1.11B
SUPPLEMENTAL
Shares Outstanding 79.36M 77.77M 73.26M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $136.31M $75.10M $44.22M
Capital Expenditures $9.68M $11.29M $9.96M
Cash from Investing $-9.21M $-56.28M $15.11M
Cash from Financing $-4.22M $4.90M $2.84M
Free Cash Flow $126.63M $63.81M $34.26M
Beginning Cash (CFS) $240.63M $217.33M -
Net Change in Cash $122.88M $23.73M -
Effect of FX on Cash $719.00K $-424.00K $163.00K
Calculated Ending Cash $364.23M $240.63M -
Cash per BS $362.58M $239.09M $216.45M
Cash scope difference (CFS − BS) $1.65M $1.54M $876.00K
Cash per CFS $364.23M $240.63M $217.33M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is VERACYTE, INC.'s annual revenue?

VERACYTE, INC. reported $561.90M in revenue for trailing twelve months (ending June 2026). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is VERACYTE, INC. profitable?

Yes. VERACYTE, INC. reported $114.48M in net income for trailing twelve months. Profitability data is based on the company's most recent annual report filed with the SEC.

Does VERACYTE, INC. generate free cash flow?

Yes. Free cash flow was $165.99M for trailing twelve months. Operating cash flow was $178.38M.